Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States ...

The vote clears the way for a proposed multibillion-dollar expansion of the former Nexus Pharmaceuticals facility.

and the fourth would produce sterile injectable medicines such as diabetes drug Mounjaro, Lilly said Wednesday. The company hasn’t picked the locations yet. It expects the plants to be making ...

Eli Lilly introduced Mounjaro, a diabetes and weight-loss drug, in India, aiming to tackle obesity and diabetes. With a ...

Lilly has been working to increase manufacturing capacity to meet the massive demand for its blockbuster diabetes and weight-loss drugs Zepbound and Mounjaro. The drugs have been in shortage for ...

Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States ... including the popular weight-loss drug Mounjaro. Eli Lilly said the investment ...

The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...

Eli Lilly said Wednesday it will build three manufacturing plants in the United States to ... s top-selling diabetes and weight-loss drugs Mounjaro and Zepbound. A fourth facility will make ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...